| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.26 | 5e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |